- Report
- October 2025
- 160 Pages
Global
From €2829EUR$3,160USD£2,424GBP
€3536EUR$3,950USD£3,030GBP
- Report
- July 2026
- 160 Pages
Global
From €3715EUR$4,150USD£3,184GBP
- Report
- April 2026
- 160 Pages
Global
From €2972EUR$3,320USD£2,547GBP
€3715EUR$4,150USD£3,184GBP
- Report
- October 2025
- 160 Pages
Global
From €2829EUR$3,160USD£2,424GBP
€3536EUR$3,950USD£3,030GBP
- Report
- October 2025
- 160 Pages
Global
From €2829EUR$3,160USD£2,424GBP
€3536EUR$3,950USD£3,030GBP
- Report
- October 2025
- 160 Pages
Global
From €2829EUR$3,160USD£2,424GBP
€3536EUR$3,950USD£3,030GBP
- Report
- April 2026
- 107 Pages
Global
From €3500EUR$4,188USD£3,104GBP
- Report
- April 2026
- 110 Pages
Global
From €3500EUR$4,188USD£3,104GBP
- Report
- April 2026
- 131 Pages
Global
From €3500EUR$4,188USD£3,104GBP
- Report
- April 2026
- 130 Pages
Global
From €4342EUR$4,850USD£3,721GBP
- Report
- March 2026
- 140 Pages
Global
From €4342EUR$4,850USD£3,721GBP
- Report
- June 2026
- 130 Pages
Global
From €4342EUR$4,850USD£3,721GBP
- Report
- June 2026
- 53 Pages
Global
From €6714EUR$7,500USD£5,754GBP
- Report
- April 2026
- 200 Pages
United States
From €2677EUR$2,990USD£2,294GBP
- Report
- April 2026
- 75 Pages
United States
From €4252EUR$4,750USD£3,644GBP
- Report
- April 2024
- 325 Pages
Global
From €5254EUR$6,074USD£4,350GBP
- Report
- January 2025
- 429 Pages
Global
From €4431EUR$4,950USD£3,798GBP
- Report
- April 2025
Global
From €4387EUR$4,900USD£3,759GBP
- Report
- June 2026
- 120 Pages
Mexico
From €2685EUR$2,999USD£2,301GBP
- Report
- July 2024
- 100 Pages
Global
From €5327EUR$5,950USD£4,565GBP

The Cardiac Rhythm Management (CRM) market is a segment of the cardiovascular devices industry. It includes a range of products and services used to diagnose and treat cardiac arrhythmias, or abnormal heart rhythms. These products include pacemakers, implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, and cardiac ablation systems. CRM products are used to monitor and regulate the electrical activity of the heart, helping to restore normal rhythm and improve patient outcomes.
CRM products are used in a variety of clinical settings, including hospitals, clinics, and ambulatory care centers. The market is driven by technological advancements, such as miniaturization of devices and the development of new features, as well as an increasing prevalence of cardiovascular diseases.
Notable companies in the CRM market include Medtronic, Abbott, Boston Scientific, Biotronik, and LivaNova. Show Less Read more